1. Ali H, Mohamed MM, Sharma A, Fulop T, Halawa A. Outcomes of interleukin-2 receptor antagonist induction therapy in standard-risk renal transplant recipients maintained on tacrolimus: a systematic review and meta-analysis. Am J Nephrol. 2021;52(4):279–91.
2. Ali H, Sharma A, Halawa A. Effect of interleukin-2 receptor antibody induction therapy on survival in renal transplant patients receiving tacrolimus. Am J Nephrol. 2020;51(5):366–72.
3. Ali H, Mohiuddin A, Sharma A, Shaheen I, Kim JJ, El Kosi M, et al. Implication of interleukin-2 receptor antibody induction therapy in standard risk renal transplant in the tacrolimus era: a meta-analysis. Clin Kidney J. 2019;12(4):592–9.
4. Buttigieg J, Ali H, Sharma A, Halawa A. Positive luminex and negative flow cytometry in kidney transplantation: a systematic review and meta-analysis. Nephrol Dial Transplant. 2019;34(11):1950–60.
5. Tambur AR. HLA-DQ antibodies: are they real? Are they relevant? Why so many? Curr Opin Organ Transplant. 2016;21(4):441–6.